Therefore, removal of the potentially suppressive myeloid cell populations from the peripheral blood of adenocarcinoma patients before analysis of T cell responses might reveal a higher percentage of XAGE-1b-specific T cell responders among Caucasian patients. Here, XAGE1B is linked to adenocarcinoma.